| Date Filed | Type | Description |
| 10/04/2023 |
4
| Li Dean Y (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 1,659 shares
@ $0
Gifted 627,705 shares
@ $0 |
|
| 07/06/2023 |
4
| Li Dean Y (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 1,609 shares
@ $0 |
|
| 05/04/2023 |
4
| Li Dean Y (Executive VP & President, MRL) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 77,455 options to buy
@ $117.89, valued at
$9.1M
|
|
| 04/05/2023 |
4
| Li Dean Y (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 1,724 shares
@ $0 |
|
| 01/25/2023 |
4
| Li Dean Y (Executive VP & President, MRL) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 3,275 shares
@ $109.88, valued at
$359.9k
|
|
| 01/05/2023 |
4
| Li Dean Y (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 1,573 shares
@ $0 |
|
| 10/05/2022 |
4
| Li Dean Y (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 1,092 shares
@ $0 |
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2022 |
4
| Li Dean Y (Executive VP & President, MRL) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Exercised 773 shares
@ $87.65, valued at
$67.8k
Paid exercise price by delivering 381 shares
@ $87.65, valued at
$33.4k
Exercised 773 restricted stock units
@ $0 |
|
| 05/03/2022 |
4
| Li Dean Y (Executive VP & President, MRL) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Exercised 1,061 shares
@ $88.69, valued at
$94.1k
Paid exercise price by delivering 523 shares
@ $88.69, valued at
$46.4k
Exercised 1,061 restricted stock units
@ $0 |
|
| 04/05/2022 |
4
| Li Dean Y (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 1,544 shares
@ $0 |
|
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Li Dean Y (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 659 shares
@ $0 |
|
| 12/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 11/19/2021 |
4
| Li Dean Y (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 5,626 shares
@ $20.0384, valued at
$112.7k
Sold 13,474 shares
@ $20.2038, valued at
$272.2k
|
|
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/15/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/02/2021 |
4
| Li Dean Y (Executive VP & President, MRL) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 3,485 shares
@ $72.62, valued at
$253.1k
|
|
| 01/07/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |